Navigation Links
25 Clinical Abstracts at National Conference Spotlight Clinical Utility of Somanetics INVOS System in Neonates
Date:5/6/2009

oxygen levels in patients at risk for restricted or no blood flow. It helps hospital critical care teams detect and correct blood oxygen deficiencies that can cause brain and vital organ area damage. Sensors simply adhere to the skin like a Band Aid(R). In infants and neonates the most commonly monitored areas are the brain, abdomen and kidney area.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight. The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes in patients above 2.5 kilograms, and is the only cerebral/somatic oximeter system cleared for use on neonates less than 2.5 kg. Surgeons, anesthesiologists and other medical professionals can use data provided by the INVOS System, in conjunction with other available data, to identify oxygen imbalances in brain or other body tissue beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with an 11-year market track record, more than 600 clinical references and implementation at more than 700 U.S. hospitals. Somanetics also is developing a technology that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents IN
'/>"/>

SOURCE Somanetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Baptist Health South Florida Selects Clinical Performance Benchmarking Solution From Thomson Reuters
2. ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
3. Health Reform Bill Should Include Clinical Preventive Services, Businesses and Health Advocates Urge Congressional Leaders
4. SironaHealth to Provide 24 x 7 Nurse Line and Clinical Outreach to EosHealth as part of their Mobile Health & Wellness Programs
5. Physician and Author to Share Clinically Proven System for Permanent Weight Loss and Optimal Health in Westerville and Dublin, Ohio Areas
6. Management Health Solutions, Inc. Announces Release v1.0 to Clinical Inventory Valuation Solution
7. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
8. Prime Clinical Systems Participating in American College of Physician's EHR Partners Program
9. German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAKs CRO Connect Program(TM)
10. Anti-aging cosmetic reduced wrinkles in clinical trial
11. Locum Leaders Links Physicians to New Jobs and Clinical Education Through Social Media

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
(Date:11/25/2009)... Evaluation and treatment clinics to re...odstock (Vocus) November 25, 2009 -- Centegra Heal...es and H1N1 vaccine shots at four Centegra Primary...ment of vaccine has arrived. The clinics are at CP...Henry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...Currently lie detection methods use heart activity... quite accurately for lie detection reports the on...n scientist Pankaj Pasricha at the University of T...own - literally. It has its own well-developed ner...
... The government of India has today assured that th...a) in the country // The government has set...se eye on the on the domestic poultry population a...ose watch on the situation. Extensive surveillance...
... A new study indicates that there maybe gender dif...cer and women who smoke and drink maybe at higher...r Anna L. Zisman, M.D. of Evanston Northwestern He...hol use are well-established risk factors for colo...
...tudy was conducted to investigate the association ... density (BMD), and cardiovascular risk factors. T...her bone mineral // density than the controls, and...diabetics have bone mass alterations and may have ...
...-mediated bone marrow injury is an early or predis...d persistent hematopoietic disease, according to r...r 23 in the journal Leukemia Research. My...s, clonal evolution and a tendency to progress on ...
...ers have been used widely in the treatment of hype...rugs in hypertension guidelines. Moreover, after m...ilure, treatment // with beta blockers prevents re...hypertension. A recent study, published in t...
Other Medicine News:Health News:Women More Prone To Risk of Colorectal Cancer from Tobacco 2Health News:Diabetic Type II Women Have Elevated Bone Density Mass 2Health News:Evidence against use of Beta blockers as first choice in the treatment of primary hypertension 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
(Date:11/24/2009)...Newswire-FirstCall/--QuestDiagnosticsIncorporated(...esting,informationandservices,announcedthatitissch...ConferenceinNewYorkCity.Thepresentationisscheduled...,, Duringtheconference,thecompanywillreaffirmit...tingincometoexceed18%ofrevenues,anddilutedearnings...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 1LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 3Accera Inc to Present at UBS Global Life Sciences Conference 57667 1Accera Inc to Present at UBS Global Life Sciences Conference 57667 2Ulcer Preventative May Raise Pneumonia Risks 57664 1Ulcer Preventative May Raise Pneumonia Risks 57664 2
...SINESS WIRE)--Jun 13, 2007 - EPIX,Pharmaceuticals,...m,its Phase 3 trial of PRX-00023, a novel long-act...ntation at the 47th Annual New,Clinical Drug Evalu... The meeting is sponsored by the National Institut...Psychopharmacology., The presentation highlighted ...
...-(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharm...he Tel,Aviv Stock Exchange Exchange, proceeds with...in addition to CF101, which is currently,in clinic...s. This,weekend Can-Fite will present at the EUALR...ivo study results showing effective,anti-inflammat...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
HemoCue 201 DM System, Glucose
Triage® C. difficile Panel
Bartels® C. Difficile Toxin A Antigen EIA with Controls
... Toxin A C. difficile Rapid Toxin A Test gives you...minutes. When it might be C. difficile, you can't ...nly a few tests a day or sends out its suspected C...C. difficile Rapid Toxin A Test will cut costs and...
Medicine Products: